EMCDDA Home
  • EN
Search

Table TDI-111. Frequency of use of primary drug of clients entering outpatient treatment, 2011 or most recent year available

Part (vi) All stimulants (other than cocaine) outpatient clients by country and frequency of use (%)

CountryNot used in the past month/ OccasionalOnce a week or less2 - 6 times per weekDailyFrequency known (n) Frequency unknown
Belgium55.06.019.319.636738
Bulgaria50.010.020.020.0100
Czech Republic55.818.115.410.783969
Denmark21.851.326.829856
Germany
Estonia25.08.325.041.7121
Ireland130.832.329.27.7651
Greece25.037.512.525.0160
Spain122.315.336.126.3543111
France27.916.816.239.117999
Italy25.040.314.540.315916
Cyprus21.47.17.164.3140
Latvia34.52837.330.2311110
Lithuania
Luxembourg
Hungary50.618.218.213.153416
Malta14.837.033.314.827
Netherlands25.39.622.242.8446338
Austria50.513.920.814.91016
Poland42119.84217.3812
Portugal557.128.614.370
Romania66.733.330
Slovenia
Slovakia13.721.338.027.026310
Finland42.428.325.34.09921
Sweden136.915.930.117.149171
United Kingdom6
Croatia72.117.14.56.31118
Turkey
Norway34.821.74.339.1232
Total34.118.025.722.14999975
 

Notes:

: Indicates no data are available.

Percentages are of clients whose frequency of use is known (n)

(1) Data are from 2010

(2) In 2011 around 27% of all clients and 32% of new clients were registered as not known / missing for the primary drug category. Caution should be made when comparing data over time.

(3) In 2010 Latvia submitted a new dataset with a more precise TDI EMCDDA definition. Caution should be made when comparing data with previous years.

(4) Data are from 2010. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data.

(5) In 2010 came into implementation a new national information system implying methodological changes particularly in the registration criteria. Caution should be made when comparing 2010 data with previous years.

(6) Data are from 1st of April 2010 to 31st March 2011.

See also Table TDI-18 part(i), part(ii)

‘General notes for interpreting data'’ on the Explanatory notes and help page.

Source:

Reitox national reports 2012- Table TDI Outpatient Treatment Centres

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Friday, 26 April 2013